… to negotiate prices on select medications with pharmaceutical companies, per USA Today … Januvia Jardiance Imbruvica NovoLog Stelara Xarelto Cancer drugs Keytruda and Opdivo will … , to slash prices on drugs and pharmaceuticals by as much as 400 …

… using Enbrel, Imbruvica, or Stelara will still face higher monthly … pocket cap on Medicare prescription spending, limiting total drug costs for beneficiaries … milestone for affordability in prescription drugs. While Medicare enrollees are seeing relief …

… signal meaningful progress in broadening treatment options, improving affordability, and … Hikma Pharmaceuticals) received FDA approval as a biosimilar to ustekinumab (Stelara; Janssen Biotech), based … was supported by phase 3 trial data in patients with …

… Johnson & Johnson and Janssen Biotech, Inc. (collectively, J&J … the relevant product market is STELARA® and biosimilar ustekinumab products, while … the pharmaceutical industry begins with identifying therapeutic alternatives for the drug at …

… Syringes ‘NIPRO’, a biosimilar referencing Stelara (ustekinumab), in Japan. Ustekinumab is … commercialization by NIPRO immediately after drug listing. “With this biosimilar … access to high-quality, affordable treatment options for patients with autoimmune …

… biosimilar to the autoimmune disease treatment Stelara. Stelara, which targets the immune … and ulcerative colitis. The drug is one of the … The approval will help improve treatment access for patients with … a phase 3 clinical trial involving 503 patients with …

… Johnson’s autoimmune blockbuster Stelara (ustekinumab), through local partner … listed on Japan’s drug price reimbursement schedule … treatment, and describes the product as a biosimilar referencing Stelara … takes charge of commercialization.  Stelara, an IL-12…

… most commonly prescribed medications. Some Medicare drugs are about to … the Centers for Medicare and Medicaid Services selected 10 drugs: Eliquis, Enbrel, … Entresto, Farxiga, Fiasp and Novolog, Imbruvica, Januvia, Jardiance, Stelara …

… how Medicare beneficiaries are facing fewer options, more treatment … the board identified three medications— Enbrel, Stelara, and Cosentyx — as … limits on drugs hampers research, as pharmaceutical companies may … drugs. In the case of Trikafta, which the FDA …

… focused on innovative pharmaceuticals and medical devices. The company … from its blockbuster drug Stelara begin to decline … FDA approval for Inlexzo, a new bladder cancer treatment … drug Rybrevant moved closer to broader adoption after receiving positive trial …